Jeffrey D Abbey Net Worth & Insider Trades

Jeffrey D Abbey - CEO, Argos Therapeutics Inc

As of December 17, 2015

What is Jeffrey D Abbey's Net Worth?

The current estimated net worth of Argos Therapeutics Inc's CEO, Jeffrey D Abbey, is estimated to be about $58.01K . Jeffrey D Abbey owns about 10,500 units of Argos Therapeutics Inc common stock. In the last year at Argos Therapeutics Inc, Jeffrey D Abbey has sold an estimated value of $0 worth.

What is Jeffrey D Abbey's Past Insider Trading?

Jeffrey D Abbey's largest purchase order was 5,500 units , worth over $26.15K on August 21, 2015. In total, Jeffrey D Abbey has made about 6 transactions over a year of their time at Argos Therapeutics Inc. Jeffrey D Abbey usually trades in December, with the busiest year in 2015. The most recent transaction was a purchase order of 5,000 units , worth over $12.49K on December 17, 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Jeffrey D Abbey's Salary in 2016?

As CEO of Argos Therapeutics Inc, Jeffrey D Abbey has a total base salary of $450,000 . Jeffrey D Abbey received compensation valued at about $1,862,869 in 2016 after becoming CEO. The vast majority of their compensation came in the form of a bonus of $356,500 , option awards of $1,029,892 , and other compensation of $26,477 .

What is Jeffrey D Abbey's' Mailing Address?

  • Mailing address is Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 NC

Argos Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Jeffrey D. Abbey 2016 $450,000 $356,500 $1,029,892 $26,477 $1,862,869
Jeffrey D. Abbey 2015 $450,000 $202,500 $714,502 $14,861 $1,381,863
Charles A Nicolette, Ph.D. 2016 $325,000 $121,875 $720,925 $18,669 $1,186,469
Charles A Nicolette, Ph.D. 2015 $325,000 $108,875 $446,564 $17,217 $897,656
Lee F. Allen, M.D., Ph.D. 2016 $407,292 $389,375 $1,016,592 $70,120 $1,883,379
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm

What are Argos Therapeutics Inc's Past Insider Trades?

Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer,  Pharmstandard Co Stock Joint,  and Sa International Pharmstandard .

ARGOS THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1